Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Coherus BioSciences Inc. News

FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.

Coherus was cleared by the FDA for a drug that's similar to AbbVie's Humira. Coherus plans to launch the psoriasis treatment in July 2023.

Five Below, Splunk, Snap: 'Mad Money' Lightning Round

Jim Cramer weighs in on Five Below, Splunk, Snap, Crown Castle, Square, 3D Systems, Dana, Alibaba, Coherus Biosciences.

The One-and-Wait Plan: Cramer's 'Mad Money' Recap

Jim Cramer's got a plan: Fed Chairman Jay Powell should hike once, then wait -- and maintain the independence of the Fed.

Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Even with Monday's sharp reversal, Jim Cramer says he still likes this market.

Biotech Movers: Acceleron, Clovis, Coherus

Acceleron Pharma, Clovis Oncology and Coherus BioSciences premarket trading on Tuesday.

Breaking News

Costco Raises Prices While Target Lowers Them

Costco and Target face different problems. Here's how it affects shoppers.

What's a McDonald's McNasty (and How Do You Get One)?

Menu-hacking fans may know this one.

Kohl's Stock Surges On Exclusive Sale Talks With Franchise Group

"The purpose of the exclusive period is to allow FRG and its financing partners to finalize due diligence and financing arrangements," Kohl's said.

Walmart, Amazon, Home Depot Stock Slump As Target Signals Big Summer Discounts For Overstocked Retailers

Retailers are sitting on some of the highest levels of inventory in two years, while consumers are getting lashed by surging inflation. That could mean big summer discounts for cash-strapped shoppers.